IHH Healthcare - DBS Research 2024-12-02: Powered By Solid Core Performance

• IHH Healthcare (SGX:Q0F)'s 9M24 PATMI (ex EI and MFRS 129) of MYR1.7bn was up 21% y-o-y on strong core performance, above expectations. 9M24 revenue grew 15% y-o-y (+24% fx neutral) to MYR18.1bn, led by strength across all segments.
• - Read this at SGinvestors.io -

Another quarter of sustained core growth

• The growth in IHH Healthcare’s core hospital and healthcare segment was attributed to sustained demand for healthcare services, higher revenue intensity, and inflation-adjusted price adjustments. 9M24 PATMI of MYR1.7bn was up 21% y-o-y, in part due to a lower effective tax rate of 12.6% (vs. 23.2% in 9M23) in relation to deferred tax credits at Acibadem.
• - Read this at SGinvestors.io -

Growth trajectory to continue with robust capital management measures in place.

• Read more at SGinvestors.io.

Above is an excerpt from a report by DBS Group Research.
Clients of DBS may access the full PDF report @ https://www.dbs.com/insightsdirect/.

Read also DBS's most recent report:
2025-09-01 IHH Healthcare - “Out Of Hospital” Strategy Drives Multi-pronged Benefits.

Previous report by DBS:
2025-03-03 IHH Healthcare - Consistent Strength In Core Operations.

Price targets by other brokers at IHH Healthcare Target Prices.

Listing of research reports at IHH Healthcare Analyst Reports.

Relevant links:
IHH Healthcare Share Price History,
IHH Healthcare Announcements,
IHH Healthcare Dividend Payout Dates & Corporate Actions,
IHH Healthcare News